Italian Vaccination Reaches Academic Staff

Elena Cellai, Coordinator of Master in Vaccinology and Drug Development has taken the AstraZeneca Oxford vaccine.
Special thanks to Prof. Dr. Andrew Pollard, Professor of Paediatric Infection and Immunity at the University of Oxford who leads the COVID-19 vaccine project and is a Faculty member of Master in Vaccinology and Drug Development and Prof. Sue Ann Costa Clemens Head and Prof. of Institute for Global ,Principal Investigator in Brazil for the Oxford vaccine trial, for making COVID-19 vaccine a reality.

A Decade of passion for education – Training Future Leaders

A decade of the Master in Vaccinology and Drug Development

Dear Sponsors, Faculty Members and Partners,

With great pleasure, the master program has celebrated this year, the opening of the 6th edition and 10 years of the program.

Exactly this year the program could also offer 25 student positions and counts with double number of sponsors.

This is still the only high education program degree in this field, with internationally recognized academic and scientific quality of the content and its faculty.

The graduates are leaving their handprints in the world, helping us to improve Global Health.

The IFGH has the greatest appreciation and deepest gratitude to all of you that has, with your talent, passion, dedication, expertise, guidance, advise and grants helped to keep this program alive and expanding at each edition.

Sue Ann and Master team

Mangia 2019 award to Prof. Montomoli

To Prof. Emanuele Montomoli the Mangia 2019 Award

The handover ceremony was on 15 August

The Consistory of the Monte del Mangia has decided to award the Mangia 2019 award, the highest civic recognition of the city of Siena, to Professor Emanuele Montomoli, Ordinary of Hygiene and Preventive Medicine of the Department of Molecular and Developmental Medicine of the University of Siena. The handover ceremony was on August 15th at the Theatre of the Renewed in Siena.

Responsible for numerous national and international scientific programs, of particular importance the scientific coordination of 23 European partners on the FLUCOP project funded by the European Community Professor Montomoli is the author of more than 100 scientific works that carry his signature in international journals, as well as being founder of the VisMederi Company, engaged in the field of life sciences and biotechnology working globally in collaboration with the most important vaccine companies.

Professor Montomoli has won numerous national and international awards and awards in the scientific and entrepreneurial fields, contributing significantly to the spread of the Siena scientific school and to increase the prestige of the city of Siena.

The University of Siena hosts training for National Influenza Centres

A training workshop on Laboratory Quality Management and Biosafety was held at the University of Siena (Italy) from 23-27 July 2018 to support the achievement of the PIP Framework goal of improving pandemic preparedness and response, by strengthening global laboratory surveillance capacity.

Further information at:

Alumni workshop 2017

Alumni Workshop: Beyond capacity building November 15 & 16, 2017, Lyon

The University of Lyon hosted the Institute for Global Health (IFGH) University of Siena- First Alumni Workshop (“Beyond Capacity Building”) of the Master in Vaccinology and Pharmaceutical Clinical Development. The event was held on November 15 and 16, 2017 at the Université De Lyon, France.
Sponsors, worldwide vaccines experts and more importantly, THEM: THE ALUMNI, of the unique Master in Vaccinology were present at the event.

The meeting was opened by the Alumni and followed by the University of Siena, President Prof Francesco Frati, and the Program Directors Prof. Sue Ann Costa Clemens and Prof. Emanuele Montomoli .
Dr. Bernadette Hendrickx, program faculty and master of ceremony had the great honor to introduce Dr. Alain Mérieux and the faculty of the program, amongst other important guests: Prof. Pierre Van Dame ( Univ. Antwerp), Dr. Ralf Clemens (BMGF, IVI), Baron Jean Stephenne, Dr. Nathalie Garcon (BioAster), Dr. Lutz Hegeman (Novartis), Dr. John Weil (Takeda Vaccines), Dr. Age Noerdal (CEPI), Drs. Thy Pham and Thandi Onami (Bill and Melinda Gates Foundation), Dr. Marie Jose Quentin (Sanofi Pasteur) and upper management of the University of Lyon, Prof. Martinot, as well as other participants from Paxvax, MedCago, Valneva, Curevac, IAK, Vaxtrials, Fidec, FCD.

“It is a matter of great pride to see the Masters in Vaccinology projects reaching such astounding heights and success. It only speaks of the vision and continuous hard work by the management, academic staff and sponsors. Please accept my heartfelt facilitations and congratulations on this achievement.”

Dr. Ahmad Arslam (Master 2nd edition)- speaker at the event opening

“I think all of my success now coming from the benefit of Master. This course take me go deeply in vaccinology and become a well known on vaccine, EPI and vaccine trial in Vietnam. I am so proud to say that I was a Master student in Sienna”

Dr. Trong Toan (Master 2nd Edition) speaker at the event

“This is a great achievement for me and I would like to thank you once again for all your support and more than that for giving me the change of being part of something unique, the Masters in Vaccinology.”

Dr. Alex Bica (Master 4th edition ) about thesis to be published by the European Journal of Public Health. The manuscript is entitled “Vaccination policies of immigrants in the EU/EEA Member States – the measles immunisation example”